Rodriguez, Alfredo E <br/><br/>
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis.  [electronic resource] 

 -  Current pharmaceutical design  2018 
 - 465-477 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>1873-4286 
<br/><br/><label>Standard No.: </label>10.2174/1381612824666180108121834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Clopidogrel--adverse effects<br/>Humans<br/>Observational Studies as Topic<br/>Percutaneous Coronary Intervention<br/>Prasugrel Hydrochloride--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Registries<br/>Ticagrelor--therapeutic use